Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A randomized clinical trial of the combination of Plinabulin (Plin) plus Pegfilgrastim (Peg) versus (vs) Peg alone for TAC (docetaxel, doxorubicin, cyclophosphamide) induced Neutropenia (CIN) Blayney, D., Ogenstad, S., Shi, Y., Zhang, Q., Sun, T., Du, L., Huang, L., Mohanlal, R. CHURCHILL LIVINGSTONE. 2019: S21
View details for Web of Science ID 000461694000046